Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can AI and Value-Based Care Tackle the Chronic Disease Crisis?
Management & Administration Can AI and Value-Based Care Tackle the Chronic Disease Crisis?

The United States faces a daunting challenge with chronic diseases forming a significant share of deaths and disabilities due to poor management. These illnesses, including heart disease, cancer, diabetes, obesity, and hypertension, are responsible for five out of ten leading causes of mortality,

Is South Africa's NHI Act a Threat to Private Healthcare?
Management & Administration Is South Africa's NHI Act a Threat to Private Healthcare?

The National Health Insurance (NHI) Act in South Africa has become a focal point of heated debate, with significant implications for both the country's public and private healthcare sectors. At the heart of this issue is the legal challenge mounted by the Health Funders Association (HFA), which

How Can We Enhance Health Beyond Medical Care?
Management & Administration How Can We Enhance Health Beyond Medical Care?

In the modern healthcare landscape, the realization that health is shaped by societal factors, known as social determinants of health, has gained momentum. Factors such as access to education, economic stability, housing, and food security play significant roles in influencing one's health journey.

How are Digital Health Firms Tackling Economic Uncertainties?
Tech & Innovation How are Digital Health Firms Tackling Economic Uncertainties?

In an era marked by economic instability, digital health firms face unique challenges and opportunities. With fluctuations in tariffs, unpredictable regulatory climates, and market volatility, these companies are compelled to recalibrate their strategies to remain resilient and seize growth

West Pharmaceutical: Strong Growth Potential Despite Current Price
Clinical & Pharma West Pharmaceutical: Strong Growth Potential Despite Current Price

In recent market activities, West Pharmaceutical Services, Inc. has experienced significant investor interest following a notable 11% increase in its share value on the NYSE. This movement has piqued curiosity regarding the company's real worth and potential avenues for growth. This comprehensive

Can Dreem Health Revolutionize Sleep Care with Tech and Insurers?
Tech & Innovation Can Dreem Health Revolutionize Sleep Care with Tech and Insurers?

The landscape of sleep care is undergoing a significant transformation as Dreem Health joins forces with major insurers such as Humana. This collaboration is poised to address pervasive sleep issues by integrating advanced technology into healthcare. As sleep's critical role in health gains wider

Can Science Thrive Without Lab Animals? Exploring New Tech
Clinical & Pharma Can Science Thrive Without Lab Animals? Exploring New Tech

In the evolving domain of scientific research, the age-old reliance on laboratory animals is being critically evaluated, driven by the dual pressures of ethical considerations and the quest for more accurate human-related research outcomes. The traditional model, which involves experimenting on

Rural Libraries Bridge Healthcare Gap with Telehealth Booths
Tech & Innovation Rural Libraries Bridge Healthcare Gap with Telehealth Booths

Amidst scenic landscapes and vast expanses, New Mexico's rural communities face profound difficulties in accessing healthcare services due to geographical isolation. Deirdre Caparoso’s innovative project—transforming public libraries into hubs for telehealth consultations—is reshaping how

Pioneering AI Researcher Tackles Medical Inconsistencies
Tech & Innovation Pioneering AI Researcher Tackles Medical Inconsistencies

In the realm of medical technology, artificial intelligence (AI) presents immense possibilities and potential pitfalls necessitating innovative solutions. Umaima Rahman, a 29-year-old distinguished Indian researcher, has emerged as a trailblazer in this delicate field, addressing critical issues

Medtronic to Spin Off Diabetes Division in Strategic Realignment
Tech & Innovation Medtronic to Spin Off Diabetes Division in Strategic Realignment

In an era where strategic precision dictates corporate success, Medtronic's decision to spin off its diabetes division as a standalone entity captures significant attention in both the medical technology sector and broader financial markets. This transformative strategy is set to redefine market

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later